The stock of Tiziana Life Sciences Ltd (NASDAQ:TLSA) increased by $0.21 on Tuesday to $0.81, up 34.63 percent. The last five days have seen an average of 5,181,328 shares of common stock traded. 17 times new highs were reached in the current year, with a gain of $0.1959. The average number of shares traded over the last 20 days was 1,329,367, while the average volume over the last 50 days totaled 643,305.
TLSA stock appreciated 21.29% since last month. On 08/14/23, the company’s shares reached a one-month low of $0.6000. The stock touched a high of $1.39 on 04/19/23, after rallying from a low of $0.50 in 52 weeks. The price of TLSA stock has risen by 35.49% or $0.1959 this year, reaching a new high 17 times. Still, the stock price is down -41.78% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
For the recent quarter, Tiziana Life Sciences Ltd’s quick ratio was 3.60, while its current ratio was 3.60, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the recent quarter is 0.01, and the total debt to equity ratio is 0.02. Based on annual data, it had gross profit of $7000.0 and revenue of $14.59 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. TLSA’s return on assets (ROA) during the last 12 months has been -40.40%. In the meantime, the return on equity (ROE) for the last 12 months was -48.90%.
Technical Picture
Here’s a quick look at Tiziana Life Sciences Ltd’s (TLSA) price momentum from a technical perspective. As of 14 August, the RSI 9-day stood at 74.94%, suggesting the stock is Overbought, with a 143.43% historical volatility rate.
The stochastic %K and %D were 19.01% and 15.21% respectively, while the average true range (ATR) was 0.0681. Based on the 14-day stochastic reading of 54.00%, the RSI (14) reading is 67.60%. On the 9-day MACD Oscillator, the stock is at 0.0171, and the 14-day reading is at 0.0196.
Analyst Ratings
In its analyst report released on December 22, 2020, B. Riley Securities began covering Tiziana Life Sciences Ltd (NASDAQ: TLSA). The stock was rated as a Buy by the brokerage firm. Analysts have assigned Tiziana Life Sciences Ltd (TLSA) an Buy rating. TLSA is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.
What is TLSA’s price target for the next 12 months?
The current consensus forecast for the stock is between $2.42 and $2.42, with a median target price of $2.42. In analyzing these forecasts, the average price target given by analysts for Tiziana Life Sciences Ltd (TLSA) is $2.42.
